Enclara Pharmacia Announces the Appointment of Mark Morse as CEO
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201014005070/en/
Mark Morse, Chief Executive Officer, Enclara Pharmacia (Photo: Business Wire)
Mark succeeds Andy Horowitz, Enclara founder and CEO, who made plans to move into a strategic advisor role as part of Humana’s acquisition of the pharmacy services provider in February. In the months since, Horowitz has provided direction and leadership throughout the integration process to help bring the two companies together and ensure a smooth transition. He will continue to act as a strategic advisor as part of the Humana-Enclara agreement, and remain involved in the long-term success of the company.
“A key part of our strategic plan, established when Humana agreed to acquire Enclara, was that I would transition into an advisory role when it made the most sense,” Horowitz said. “I believe we have reached a point where it is time for a new leader to execute on the roadmap we have established. I’m really proud of the entire Enclara team and the company we have built together, and I am confident in how Mark will lead Enclara into the future.”
Before joining Enclara, Morse most recently served as Humana’s vice president of Pharmacy Service Operations, overseeing a team of approximately 3,000 associates in 16 domestic and overseas locations. Under his leadership, Humana was named the best in Mail Order Pharmacy Customer Satisfaction in the J.D. Power U.S. 2020 Pharmacy Study, the third consecutive year Humana received this honor. Throughout his over 30-year career, Morse has also led the strategy and operations for many large-scale sales, systems and customer-focused initiatives.
“Andy and his team have built an amazing company, which serves a critical and noble need in the market and for the patients it serves,” Morse said. “I care deeply about advancing both Enclara’s growth and hospices’ capacity to provide quality end-of-life care. My goal is to leverage Humana’s scale and resources to help Enclara deliver timely and cost-effective pharmacy solutions while maintaining what makes Enclara uniquely Enclara.”
Morse’s previous roles at Humana include serving as practice leader for pharmacy benefit management sales, generating an additional $50M in annual revenue. He was also sales director for national and major accounts. Prior to joining Humana in 2001, Morse spent six years with United Healthcare, serving as the business owner for its consumer portal and operations director for health plan and systems migrations. Morse holds a Bachelor of Science in Management Systems from Rensselear Polytechnic Institute, America's first technological research university.
About Enclara Pharmacia
Enclara Pharmacia is a national full-service PBM and mail order supplier of medications and clinical services developed specifically for the hospice and palliative care industry. Enclara serves over 450 hospice providers and 97,000 patients nationally, helping to reduce pharmacy costs through a clinically driven model that enables home delivery of pharmaceuticals as well as access to a network of over 65,000 local pharmacies, including an actively-managed network subset of over 7,000 retail pharmacies, institutional pharmacies, and Enclara’s own automated fulfillment solutions.
Humana Inc. (NYSE: HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.
To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.
More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at www.humana.com, including copies of:
- Annual reports to stockholders
- Securities and Exchange Commission filings
- Most recent investor conference presentations
- Quarterly earnings news releases and conference calls
- Calendar of events
- Corporate Governance information
View source version on businesswire.com.
Enclara Marketing & Communications
Source: Enclara Pharmacia